Resveratrol modifies risk factors for coronary artery disease in swine with metabolic syndrome and myocardial ischemia
- 1 August 2011
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 664 (1-3) , 45-53
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- The effect of PPAR-α agonism on apolipoprotein metabolism in humansAtherosclerosis, 2010
- SIRT1 Exerts Anti-Inflammatory Effects and Improves Insulin Sensitivity in AdipocytesMolecular and Cellular Biology, 2009
- SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthaseProceedings of the National Academy of Sciences, 2007
- Diabetic Cardiomyopathy RevisitedCirculation, 2007
- AMP-activated protein kinase and the regulation of glucose transportAmerican Journal of Physiology-Endocrinology and Metabolism, 2006
- Retinol-Binding Protein 4 and Insulin Resistance in Lean, Obese, and Diabetic SubjectsNew England Journal of Medicine, 2006
- Cardioprotective effect of resveratrol, a natural antioxidant derived from grapesCardiovascular Research, 2000
- Relationship of MRI Delayed Contrast Enhancement to Irreversible Injury, Infarct Age, and Contractile FunctionCirculation, 1999
- Regulation of energy substrate metabolism in the diabetic heartCardiovascular Research, 1997
- Streptozotocin-induced non-insulin-dependent diabetes protects the heart from infarction.Circulation, 1993